Across TCGA pan-cancer cohorts, OR10R2 RNA is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OR10R2 data layer compared with 5 for mutation status.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR10R2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR10R2 expression acts as an unfavorable survival marker, although some lineages such as THYM show a favorable association.

STAD, KIRC, and THYM are the cancer types where OR10R2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.267	0.739	.001	45	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
THYM	OS	Tertile	II,III,IV	1.000	0.668	.007	7	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: OR10R2 tumor-vs-normal RNA expression · all OR10R2 data types